ANTIPHOSPHOTIDYL SERINE ANTIBODIES

The Antiphosphatidyl Serine Antibodies test is a blood test that detects immune proteins directed against phosphatidylserine, a phospholipid associated with cell membranes. These antibodies belong to the broader group of antiphospholipid antibodies, which may interfere with normal blood-clotting processes in some individuals. Depending on the laboratory method and the clinician's request, testing may assess IgG, IgM or other antibody classes.

Antiphosphatidylserine antibodies may be investigated in selected patients with unexplained blood clots, pregnancy complications or suspected autoimmune disease. However, they are generally considered non-criteria antiphospholipid antibodies. This means that they are not, by themselves, part of the standard laboratory criteria used to classify antiphospholipid syndrome. A positive result therefore cannot independently confirm antiphospholipid syndrome or predict that a blood clot will occur.

Benefits of the Test

• Detects antibodies directed against phosphatidylserine.
• Provides supplementary information during selected clotting evaluations.
• May support investigation when standard antiphospholipid antibody results are inconclusive.
• Can contribute to the assessment of recurrent thrombosis or certain pregnancy complications.
• Provides additional autoimmune information when interpreted with established antibody tests.
• May help the treating specialist decide whether further testing or monitoring is appropriate.

Why Doctors Recommend This Test

A doctor may recommend this test for a patient with unexplained venous or arterial thrombosis, particularly when the medical history raises concern about an autoimmune clotting tendency. Possible events include deep-vein thrombosis, pulmonary embolism, stroke or other circulation problems. Any symptoms suggesting an active clot, such as sudden breathing difficulty, chest pain, one-sided limb swelling, facial drooping or sudden weakness, require urgent medical attention rather than waiting for laboratory testing.

Testing may also be considered in selected women with recurrent pregnancy loss, fetal loss or other pregnancy complications potentially associated with placental blood flow. Many conditions can cause pregnancy complications, so a positive antibody result does not establish the cause. Evaluation should be directed by an obstetrician, rheumatologist, haematologist or another qualified specialist.

Antiphosphatidylserine antibodies may sometimes be ordered when standard antiphospholipid tests are negative but clinical suspicion remains. Standard laboratory assessment usually includes lupus anticoagulant, anticardiolipin antibodies and anti-beta-2 glycoprotein I antibodies. These established tests remain central to the classification of antiphospholipid syndrome.

Preparation Before Test

A blood sample is required. Fasting is generally not necessary when this antibody test is ordered alone. Follow the instructions provided by your doctor or Focus Diagnostics when it is combined with fasting investigations.

Inform your doctor about anticoagulants, antiplatelet medicines, immune-suppressing treatment, recent infections, pregnancy and all other medications. These details are important for interpreting the overall clotting evaluation. Do not stop warfarin, heparin, aspirin or any prescribed medicine without direct medical instructions.

Antiphospholipid antibodies can appear temporarily during infections or after other inflammatory events. For this reason, a doctor may recommend repeat testing after at least 12 weeks when persistent antibody positivity is clinically relevant. The need for repeat testing depends on the antibody type, symptoms and the complete clinical evaluation.

Normal Reporting Time

Antiphosphatidyl Serine Antibodies testing is generally reported within a few working days. The exact turnaround time can vary according to the antibody classes requested, testing schedule and whether the sample requires specialized or referral processing. Focus Diagnostics will provide the applicable reporting schedule during sample collection.

Who Should Take This Test?

This test may be appropriate for selected patients with unexplained or recurrent blood clots, certain pregnancy complications or suspected antiphospholipid-related autoimmunity. It may also be considered when standard antiphospholipid antibody tests do not fully explain a strong clinical suspicion.

It is not recommended as a routine wellness or screening test for people without relevant symptoms or medical history. Because a positive result does not necessarily indicate disease or predict a future clot, testing and interpretation should be guided by an experienced clinician.

Detailed Information

A positive result means that antibodies reacting with phosphatidylserine were detected above the laboratory's stated threshold. The clinical significance depends on the antibody class, measured level, persistence over time, symptoms and results of other antiphospholipid tests. Low-level or temporary antibodies may occur without antiphospholipid syndrome.

A negative result does not exclude antiphospholipid syndrome or every autoimmune clotting disorder. Doctors may evaluate lupus anticoagulant, anticardiolipin IgG and IgM, anti-beta-2 glycoprotein I IgG and IgM, complete blood count, coagulation studies and imaging appropriate to the patient's symptoms. Some laboratories also offer antibodies against the phosphatidylserine-prothrombin complex, which are different from antibodies directed against phosphatidylserine alone.

Diagnosis of antiphospholipid syndrome requires appropriate clinical events and persistent positivity in recognized laboratory tests according to applicable medical criteria. The result of this non-criteria antibody test should not be used alone to begin or stop anticoagulant treatment. All treatment decisions must be made by the treating physician after reviewing the risk of clotting, bleeding, pregnancy history and complete laboratory evidence.